Can rituximab be used in the treatment of pemphigus vulgaris during the COVID ‐19 pandemic?
Author:
Affiliation:
1. Cerrahpasa Medical Faculty, Department of Dermatology Istanbul University Istanbul Turkey
Publisher
Wiley
Subject
Dermatology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.14647
Reference16 articles.
1. Efficacy of repeated courses of rituximab as treatment for pemphigus vulgaris;Baum S;Acta Dermatol Venereol,2020
2. Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
3. Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19
4. Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrs
5. Immune response following infection with SARS‐CoV‐2 and other coronaviruses: a rapid review;Murchu OE;Rev Med Virol,2020
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. COVID outcome in pemphigus: Does rituximab make pemphigus patients susceptible to more severe COVID‐19?;Journal of Cosmetic Dermatology;2023-08-12
2. The Management of Autoimmune Bullous Skin Disorders in the Era of COVID-19 Pandemic: A Single Center, Retrospective, Cross-sectional Study;Journal of the Turkish Academy of Dermatology;2023-06-21
3. COVID-19 and autoimmune bullous diseases: Lessons learned;Autoimmunity Reviews;2023-04
4. Considerations for the use of immunosuppression for the management of pemphigus during the COVID-19 pandemic with a focus on rituximab: Case reports from a single center experience in Australia;Frontiers in Medicine;2023-03-14
5. Autoimmune bullous diseases during COVID-19 pandemic: 2022 update on rituximab and vaccine;Frontiers in Medicine;2023-01-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3